vTv Therapeutics (VTVT) Assets Average (2016 - 2025)
Historic Assets Average for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to $63.0 million.
- vTv Therapeutics' Assets Average rose 4052.58% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year increase of 4052.58%. This contributed to the annual value of $24.6 million for FY2024, which is 1136.12% up from last year.
- According to the latest figures from Q3 2025, vTv Therapeutics' Assets Average is $63.0 million, which was up 4052.58% from $29.2 million recorded in Q2 2025.
- vTv Therapeutics' 5-year Assets Average high stood at $63.0 million for Q3 2025, and its period low was $13.0 million during Q4 2023.
- Over the past 5 years, vTv Therapeutics' median Assets Average value was $29.2 million (recorded in 2025), while the average stood at $31.4 million.
- Per our database at Business Quant, vTv Therapeutics' Assets Average tumbled by 6226.84% in 2023 and then soared by 21389.25% in 2024.
- Quarter analysis of 5 years shows vTv Therapeutics' Assets Average stood at $28.5 million in 2021, then increased by 20.82% to $34.4 million in 2022, then crashed by 62.27% to $13.0 million in 2023, then surged by 213.89% to $40.7 million in 2024, then soared by 54.66% to $63.0 million in 2025.
- Its Assets Average was $63.0 million in Q3 2025, compared to $29.2 million in Q2 2025 and $35.1 million in Q1 2025.